Text Size

Sample Collection From Melanoma Patients

This study is currently recruiting participants.
Verified November 2012 by M.D. Anderson Cancer Center
Sponsor:
Information provided by (Responsible Party):
M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier:
NCT00507325
First received: July 24, 2007
Last updated: November 19, 2012
Last verified: November 2012
History of Changes
  Purpose

The goal of this laboratory research study is to collect blood and tumor samples from patients with malignant melanoma. Researchers want to store these samples in a secure and confidential laboratory at M. D. Anderson. Researchers will use the information that is learned in this study to help find ways to improve treatment for melanoma and other cancers.


Condition Intervention
Melanoma
 Procedure: Blood Sample
Procedure: Tumor Sample

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Blood and Tumor Sample Collection From Patients With Malignant Melanoma for Long Term Storage

Resource links provided by NLM:

MedlinePlus related topics: Cancer Melanoma
U.S. FDA Resources

Further study details as provided by M.D. Anderson Cancer Center:

Primary Outcome Measures:
  • Collection and long-term collection of blood and tumor samples from patients with malignant melanoma for future biological and/or surrogate marker studies. [ Time Frame: 6 Years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples With DNA

Patients will provide blood and tumor samples to help researchers learn about melanoma and other cancers.


Estimated Enrollment: 200
Study Start Date: June 2006
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Blood Sample + Tumor Sample
Blood samples will be collected. Tumor samples will be collected using a small needle, a punch knife, or a small surgery.
 Procedure: Blood Sample
Blood samples will be collected.
Procedure: Tumor Sample
Tumor samples will be collected using a small needle, a punch knife, or a small surgery.

  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Study participants with a diagnosis of malignant melanoma.

Criteria

Inclusion Criteria:

  1. Patients with a suspected or confirmed diagnosis of malignant melanoma. These include patients with melanoma of the soft part, spindle-cell neoplasm consistent with melanoma and choroidal melanoma.
  2. Patients who are willing to consent for this protocol.

Exclusion Criteria: None

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00507325

Contacts
Contact: Kevin B. Kim, MD 713-792-2921

Locations
United States, Texas
UT MD Anderson Cancer Center Recruiting
Houston, Texas, United States, 77030
Principal Investigator: Kevin B. Kim, MD            
Sponsors and Collaborators
M.D. Anderson Cancer Center
Investigators
Principal Investigator: Kevin B. Kim, MD M.D. Anderson Cancer Center
  More Information

Additional Information:
UT MD Anderson Cancer Center website  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: M.D. Anderson Cancer Center
ClinicalTrials.gov Identifier: NCT00507325     History of Changes
Other Study ID Numbers: 2005-0466
Study First Received: July 24, 2007
Last Updated: November 19, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by M.D. Anderson Cancer Center:
Malignant Melanoma
Blood Sample
Tumor Sample
Long-term storage
Sample Collection

Additional relevant MeSH terms:
Melanoma
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
 Neoplasms by Histologic Type
Neoplasms
Neoplasms, Nerve Tissue
Nevi and Melanomas

ClinicalTrials.gov processed this record on May 21, 2013